PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28772267-0 2017 Alpha-Lipoic Acid Alleviates High-Glucose Suppressed Osteogenic Differentiation of MC3T3-E1 Cells via Antioxidant Effect and PI3K/Akt Signaling Pathway. Thioctic Acid 0-17 thymoma viral proto-oncogene 1 Mus musculus 130-133 27796798-10 2017 In addition, our result suggests that PI3K/Akt and CREB pathways are related to the protective effect of alpha-LA. Thioctic Acid 105-113 thymoma viral proto-oncogene 1 Mus musculus 43-46 28772267-12 2017 Moreover, the PI3K/Akt pathway was activated by ALA. Thioctic Acid 48-51 thymoma viral proto-oncogene 1 Mus musculus 19-22 28772267-13 2017 CONCLUSIONS: We demonstrate that ALA may attenuate high-glucose mediated MC3T3-E1 cells dysfunction through antioxidant effect and modulation of PI3K/Akt pathway. Thioctic Acid 33-36 thymoma viral proto-oncogene 1 Mus musculus 150-153 19879292-0 2010 Alpha-lipoic acid prevents bupivacaine-induced neuron injury in vitro through a PI3K/Akt-dependent mechanism. Thioctic Acid 0-17 thymoma viral proto-oncogene 1 Mus musculus 85-88 26855124-4 2016 ALA (25 muM) significantly increased the protein synthesis and phosphorylation of Akt, mTOR, and S6 in C2C12 myotubes with attenuated phosphorylation of AMPK, Ikkalpha/beta, and eIF2alpha. Thioctic Acid 0-3 thymoma viral proto-oncogene 1 Mus musculus 82-85 26855124-11 2016 These findings indicate that ALA induces protein synthesis and the PI3K/Akt signaling pathway by TLR2. Thioctic Acid 29-32 thymoma viral proto-oncogene 1 Mus musculus 72-75 25336920-0 2014 (R)-(+)-alpha-lipoic acid protected NG108-15 cells against H2O2-induced cell death through PI3K-Akt/GSK-3beta pathway and suppression of NF-kappabeta-cytokines. Thioctic Acid 0-25 thymoma viral proto-oncogene 1 Mus musculus 96-99 25336920-6 2014 Moreover, pretreatment with R-LA stimulated the activation of PI3K-Akt through mTORC1 and mTORC2 components (mTOR, rictor and raptor) and production of antiinflammatory cytokine, IL-10 which led to the inactivation of glycogen synthase kinase-3beta (GSK-3beta) and reduction of both Bax/Bcl2 and Bax/Bcl-xL ratios, accompanied by inhibition of the cleaved caspase-3. Thioctic Acid 28-32 thymoma viral proto-oncogene 1 Mus musculus 67-70 23562296-0 2013 alpha-Lipoic acid attenuates LPS-induced cardiac dysfunction through a PI3K/Akt-dependent mechanism. Thioctic Acid 0-17 thymoma viral proto-oncogene 1 Mus musculus 76-79 23562296-3 2013 We have reported previously that alpha-lipoic acid (LA) activates PI3K/Akt pathway in neuronal cells. Thioctic Acid 33-50 thymoma viral proto-oncogene 1 Mus musculus 71-74 22982730-0 2012 Alpha-lipoic acid pre- and post-treatments provide protection against in vitro ischemia-reperfusion injury in cerebral endothelial cells via Akt/mTOR signaling. Thioctic Acid 0-17 thymoma viral proto-oncogene 1 Mus musculus 141-144 22982730-2 2012 In this study, we sought to determine whether ALA could induce pre- or post-treatment protective effects against simulated ischemia and reperfusion-induced cerebral endothelial cell (CEC) injury by activating the Akt/mTOR pathway. Thioctic Acid 46-49 thymoma viral proto-oncogene 1 Mus musculus 213-216 22982730-7 2012 Western blotting showed that the ALA pre- and post-treatments up-regulated the phosphorylation of Akt, mTOR, S6K and 4E-BP1 in both bEnd.3 cells and primary cultures. Thioctic Acid 33-36 thymoma viral proto-oncogene 1 Mus musculus 98-101 22982730-8 2012 However, after pre-treatment with rapamycin, the level of Akt phosphorylation was decreased in primary cultures of CECs but could still be restored by ALA, whereas the levels of mTOR, S6K and 4E-BP1 phosphorylation were significantly decreased and could not be restored. Thioctic Acid 151-154 thymoma viral proto-oncogene 1 Mus musculus 58-61 22982730-9 2012 These results suggest that ALA pre- and post-treatments provide protective effects against simulated ischemia and reperfusion-induced CEC injury by promoting the Akt/mTOR pathway and that mTOR is required for ALA protection. Thioctic Acid 27-30 thymoma viral proto-oncogene 1 Mus musculus 162-165